Table of contents

Original Articles: PDF Only

• DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary (1 October, 1993)

  J. Kaern, C. G. TropÉ, G. B. Kristensen, V. M. Abeler, E. O. Pettersen
• Extraperitoneal metastases after intraperitoneal chemotherapy of ovarian cancer patients with a negative second-look laparotomy (1 October, 1993)

  J. Menczer, G. Ben-Baruch, S. Rizel, H. Brenner
• Immunohistochemical study of p53 expression in endometrial carcinomas: correlation with markers of proliferating cells and clinicopathologic features (1 October, 1993)

  T. Hachisuga, K. Fukuda, M. Uchiyama, N. Matsuo, T. Iwasaka, H. Sugimori
• Ultraradical surgery for advanced carcinoma of the vulva: an update (1 October, 1993)

  M. S. Hoffman, D. Cavanagh, W. S. Roberts, J. V. Fiorica, M. A. Finan
• Surgical pathologic staging in apparent stage I endometrial carcinoma (1 October, 1993)

  C. Mangioni, G. De Palo, E. Marubini, M. Del Vecchio
• The reliability of the histologic diagnosis in colposcopically directed biopsies. A plea for LETZ (1 October, 1993)

  M. P.M. Burger, H. Hollema
• Proliferating cell nuclear antigen (PCNA) immunoreactivity in ovarian serous and mucinous neoplasms: diagnostic and prognostic value (1 October, 1993)

  N. Wilkinson, C. H. Buckley, H. Fox, R. J. Hale, L. Chawner, Li-Na Guo
• A comparison of cytology and cervicography in cervical screening (1 October, 1993)

  V. I. Kesic, W. P. Soutter, V. Sulovic, N. Juznic, M. Aleksic, A. Ljubic
• Effect of radiotherapeutic technique on local control in primary vaginal carcinoma (1 October, 1993)

  G. L. Eddy, J. M. Jenrette, W. T. Creasman